Correlation Between E-cadherin Immunoexpression and Efficacy of First Line Platinum-Based Chemotherapy in Advanced High Grade Serous Ovarian Cancer-Reference-Cited by-同舟云学术

Correlation Between E-cadherin Immunoexpression and Efficacy of First Line Platinum-Based Chemotherapy in Advanced High Grade Serous Ovarian Cancer

Published:2014-08-11 Issue:2 Volume:21 Page:347-356
ISSN:1219-4956
Container-title:Pathology & Oncology Research
language:en
Short-container-title:Pathol. Oncol. Res.

Author:

Miše Branka Petrić,Telesmanić Vesna Dobrić,Tomić Snježana,Šundov Dinka,Čapkun Vesna,Vrdoljak Eduard

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine,Pathology and Forensic Medicine

Link

http://link.springer.com/content/pdf/10.1007/s12253-014-9827-1.pdf

Reference54 articles.

1. Ferlay J, Soerjomataram I, Ervik M et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013. Available from: http://globocan.iarc.fr . Accessed on 26/May/2014

2. Carter JS, Downs LS Jr (2011) Ovarian cancer test and treatment. Female Patient (Parsippany) 36:30–35

3. SEER Cancer Statistics Factsheets: Ovary Cancer. National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/statfacts/html/ovary.html ( http://seer.cancer.gov/statfacts/html/ovary.html ). Date of access: 26/May/2014

4. Gilks CB, Prat J (2009) Ovarian carcinoma pathology and genetics: resent advances. Hum Pathol 40:1213–1223. doi: 10.1016/j.humpath.2009.04.017

5. Helleman J, van Staveren IL, Dinjens WN et al (2006) Mismatch repair and treatment resistance in ovarian cancer. BMC Cancer 6:201. doi: 10.1186/1471-2407-6-201

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MAGE-A10 Protein Expression in Advanced High Grade Serous Ovarian Cancer Is Associated with Resistance to First-Line Platinum-Based Chemotherapy;Cancers;2023-09-23

2. E-Cadherin Expression in Relation to Clinicopathological Parameters and Survival of Patients with Epithelial Ovarian Cancer;International Journal of Molecular Sciences;2022-11-19

3. Glycosphingolipids are mediators of cancer plasticity through independent signaling pathways;Cell Reports;2022-08

4. Subtyping of high grade serous ovarian carcinoma: histopathological and immunohistochemical approach;Journal of the Egyptian National Cancer Institute;2022-02-09

5. The Hallmarks of Ovarian Cancer: Actionable Genetics, Targetable Pathways, and Predictive Biomarkers;Ovarian Cancer Biomarkers;2021